AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes

First participants with Type 2 diabetes dosed in multiple ascending dose (MAD) study evaluating AdipoPharma’s first-in-class insulin sensitizer Advancement follows successful completion of the single ascending dose (SAD) phase, where PATAS was well tolerated with no serious adverse events STRASBOURG, France, Oct. 27, 2026 (GLOBE NEWSWIRE) — AdipoPharma, a clinical-stage biotechnology company developing therapies that […]

Read More

AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes

First participants with Type 2 diabetes dosed in multiple ascending dose (MAD) study evaluating AdipoPharma’s first-in-class insulin sensitizer Advancement follows successful completion of the single ascending dose (SAD) phase, where PATAS was well tolerated with no serious adverse events STRASBOURG, France, Oct. 27, 2026 (GLOBE NEWSWIRE) — AdipoPharma, a clinical-stage biotechnology company developing therapies that […]

Read More

JETOUR Showcases Future Mobility Technologies, Deepening Its Global “Travel+” Strategy

JETOUR G700 Showcases SOLAIR Technology at the 2026 Global Technology Experience Day JETOUR G700 with SOLAIR technology for off-road travel. WUHU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) — Advances in artificial intelligence and new energy technologies are expanding what vehicles can do. Ke Chuandeng, President of JETOUR’s International, said: “The future evolution of vehicles lies […]

Read More

Political Uncertainty Fuels Demand for Additional Residence and Citizenship Rights

LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) — New data shows a rising interest in additional residence and citizenship rights among wealthy families in some of the world’s most established countries, as political, regulatory and social volatility sharpens the focus on resilience and future optionality. Drawing on activity across more than 70 offices worldwide, Henley & […]

Read More

Political Uncertainty Fuels Demand for Additional Residence and Citizenship Rights

LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) — New data shows a rising interest in additional residence and citizenship rights among wealthy families in some of the world’s most established countries, as political, regulatory and social volatility sharpens the focus on resilience and future optionality. Drawing on activity across more than 70 offices worldwide, Henley & […]

Read More

Political Uncertainty Fuels Demand for Additional Residence and Citizenship Rights

LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) — New data shows a rising interest in additional residence and citizenship rights among wealthy families in some of the world’s most established countries, as political, regulatory and social volatility sharpens the focus on resilience and future optionality. Drawing on activity across more than 70 offices worldwide, Henley & […]

Read More

From Wild Potatoes to Resilient Varieties: Crop Trust and International Potato Centre Expand Potato Work in East Africa

The International Potato Center (CIP) is partnering with the Crop Trust to launch a new phase of the BOLD project. It aims to turn useful traits from potato wild relatives into a resilient new variety, while strengthening seed systems to get better potatoes into farmers’ fields. Nairobi, Kenya, Oct. 27, 2026 (GLOBE NEWSWIRE) — East […]

Read More

Lira Clinical Announces New REGEN Line — A First-of-Its-Kind Breakthrough in Regenerative Skincare

Lira Clinical REGEN PDRN+ Crème and Serum LIVERMORE, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) — Lira Clinical, a global leader in corrective and brightening skincare, is proud to announce the launch of its groundbreaking new REGEN line. REGEN is the first and only clinical skincare line formulated with Wild Salmon Stem Cell–Conditioned Media — a […]

Read More